drugset / Trial / NCT04691713
CD276 CAR-T for Patients With Advanced CD276+ Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This study is a clinical study of CD276 CAR-T in the treatment of patients with advanced solid tumors. The purpose is to evaluate the safety and effectiveness of targeting CD276 auto-chimeric antigen receptor T cells in the treatment of CD276-positive advanced solid tumors.
Timeline
- Start
- 2019-09-01
- Primary completion
- 2021-02-26
- Completion
- 2021-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CD276 CAR-T | Cell therapy | — | — |